drugset
drugset / Trial / NCT05304845

Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects

NCT05304845 ↗

Phase 1 Completed 24 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedParallel-groupOpen-labelOther

Summary

This is a randomized, open-label study to evaluate the safety/tolerability and PK/PD drug-drug interactions between DWP14012 and aspirin when administered in combination.

Timeline

Start
2022-03-21
Primary completion
2022-05-22
Completion
2022-05-22

Drugs

EvaluationDrugModalityDoseRoute
Subject ABEPRAZAN Small molecule — —
Subject Aspirin Small molecule — —

Indications

No indication recorded.